Cargando…
Evaluating Pancreatic index in Patients with and without Metabolic Syndrome
BACKGROUND Metabolic syndrome can be considered as a combination of metabolic disorders that may led to an increased risk of some diseases such type II diabetes, cardiovascular diseases, myocardial infarction, and is the cause of mortality from coronary artery disease. Its prevalence is particularly...
Autores principales: | Mohammadmirzaei, Zahra, Farahmand, Habib, Ahmadi, Jafar, Rezvan, Sajad, Noori, Enayatollah, Hormati, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531923/ https://www.ncbi.nlm.nih.gov/pubmed/34712447 http://dx.doi.org/10.34172/mejdd.2021.212 |
Ejemplares similares
-
Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide
por: Hormati, Ahmad, et al.
Publicado: (2022) -
Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin
por: Ghalehnoei, Hossein, et al.
Publicado: (2022) -
The Association of Dietary Phytochemical Index with Metabolic Syndrome in Adults
por: Dehghani Firouzabadi, Fatemeh, et al.
Publicado: (2021) -
Evaluation of EM and orthopedic residents' pain estimation about patients with limb trauma who were visited in the Emergency Department of Hazrat Rasoul Hospital
por: Farahmand, S, et al.
Publicado: (2005) -
Neurofibromatosis type 1, presenting as a rare widespread neurofibromas with cord compression
por: Vakilian, Alireza, et al.
Publicado: (2016)